Review
Accepted on 03 May 2024
Functionalized Nanoparticles to Deliver Nucleic Acids to the Brain for the Treatment of Alzheimer's Disease
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1405423
Type at least 3 characters
2,076 articles
Articles
Original Research
Accepted on 03 May 2024
Development of a New Hazard Scoring System in Primary Neuronal Cell Cultures for Drug-Induced Acute Neuronal Toxicity Identification in Early Drug Discovery
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1308547
Original Research
Accepted on 03 May 2024
Pre-Clinical Evaluation of Clinically Relevant iPS Cell Derived Neuroepithelial Stem Cells as an off-the-Shelf Cell Therapy for Spinal Cord Injury
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1390058
Original Research
Accepted on 02 May 2024
Effects of Long-Term Antipsychotic Medication on Brain Instability in First-Episode Schizophrenia Patients: A Resting-State fMRI Study Short title: Long-term Antipsychotic Medication in FES
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1387123
Review
Accepted on 02 May 2024
Drug-Induced Musical Hallucination
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1401237
Mini Review
Accepted on 02 May 2024
A Scoping Review of the Effects of Mushroom and Fungus Extracts in Rodent Models of Depression and Tests of Antidepressant Activity
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1387158
Original Research
Published on 02 May 2024
Exosomes derived from HUVECs alleviate ischemia-reperfusion induced inflammation in neural cells by upregulating KLF14 expression
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1365928
- 158 views
Original Research
Published on 01 May 2024
Exploring the link between pyrethroids exposure and dopaminergic degeneration through morphometric, immunofluorescence, and in-silico approaches: the therapeutic role of chitosan-encapsulated curcumin nanoparticles
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1388784
- 282 views
Original Research
Accepted on 30 Apr 2024
Antiseizure Properties of Fenamate NSAIDs Determined in Mature Human Stem-Cell Derived Neuroglial Circuits
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1385523
Review
Accepted on 29 Apr 2024
Mushroom-derived bioactive components with definite structures in alleviating the pathogenesis of Alzheimer's disease
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1373660
Editorial
Published on 29 Apr 2024
Editorial: Exploring the key targets and compounds that manipulate brain neurocircuits against mental disorders and psychiatric
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1411528
- 190 views
Original Research
Published on 29 Apr 2024
Erjingwan and Alzheimer’s disease: research based on network pharmacology and experimental confirmation
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1328334
- 201 views
Original Research
Published on 26 Apr 2024
Exploring the potential use of melatonin as a modulator of tramadol-induced rewarding effects in rats
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1373746
- 246 views
Original Research
Accepted on 25 Apr 2024
Comprehensive Spectroscopic and Computational Insight into the binding of vanillin with human transferrin: Targeting Neuroinflammation in Alzheimer's disease therapeutics
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1397332
Review
Accepted on 25 Apr 2024
Alzheimer's Disease and its treatment -yesterday, today, and tomorrow
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1399121
Review
Accepted on 25 Apr 2024
Pharmacological mTOR inhibitors In Ameliorating Alzheimer's Disease: Current Review and Perspectives
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1366061